Diagnosing Hantavirus: Tests, Timing & What to Tell Your Doctor

⏰ When Should You Test for Hantavirus?

Hantavirus testing should be considered when a patient presents with flu-like illness plus any of the following:

• Documented or suspected rodent exposure within the past 6 weeks
• Absence of typical upper respiratory symptoms — no runny nose, no sore throat
• Nausea, vomiting, or diarrhea accompanying the fever (present in >50% of HPS)
• New dry cough and shortness of breath following initial febrile illness
• Thrombocytopenia (low platelets) or immunoblasts on a routine blood count
• Travel to or residence in western US, Patagonia (Argentina/Chile), or other hantavirus-endemic regions
• Exposure in the context of a declared outbreak — including the 2026 MV Hondius cruise ship

In the United States, hantavirus testing is coordinated through state public health laboratories and the CDC Special Pathogens Branch in Atlanta. During declared outbreaks, emergency protocols allow same-day or next-day results. See US risk areas by state for which states have the most active hantavirus surveillance programs.

🩸 IgM/IgG ELISA: The Primary Hantavirus Blood Test

Enzyme-Linked Immunosorbent Assay (ELISA) testing for hantavirus-specific antibodies is the gold standard diagnostic test for clinical HPS. Key facts:

• IgM antibodies: Detectable at or very shortly after symptom onset — often from day 1 of symptoms. IgM positivity in a compatible clinical context indicates acute hantavirus infection. IgM typically persists for 30–60 days before declining.
• IgG antibodies: Also appear early — within days of symptom onset. This is unusually early for a viral infection and is diagnostically useful. IgG alone may indicate recent or remote past infection.
• Sensitivity: Exceeds 95% once symptoms are present. A single serum sample showing IgM positivity with compatible symptoms and exposure history is sufficient for clinical diagnosis.
• Where available in the US: State public health labs provide initial screening. LabCorp and Quest Diagnostics now offer North American hantavirus ELISA panels, improving access significantly since 2024.

Specimen: 3–10 mL of clotted blood in a serum separator tube (SST). Refrigerate and ship on ice per state lab instructions. Do not freeze — this can compromise antibody detection.

How to request it: At any emergency room or urgent care, specifically ask: "I need hantavirus IgM and IgG ELISA testing sent to the state public health lab. I have had rodent exposure and have compatible symptoms."

🔬 RT-PCR: Viral RNA Detection

Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) directly detects hantavirus RNA in patient blood or tissue. This test is most valuable in specific clinical situations:

• Very early illness (days 1–10): When viremia (circulating viral RNA) is at its peak. PCR may be positive even before IgM reaches detectable levels in a small subset of patients.
• Post-mortem diagnosis: PCR on tissue samples (particularly lung, kidney, or spleen) is the primary method for confirming hantavirus in deceased patients when serology was not obtained.
• Strain identification: Essential during outbreak investigation to confirm whether cases involve Sin Nombre, Andes, Seoul, or another strain — critically important for case management and contact tracing protocols.

Limitation: Viremia is brief. By the time many HPS patients reach hospital care (often day 5–8 of illness), viral RNA may no longer be detectable in blood — while ELISA remains positive. This is why most reference labs run both ELISA and PCR in parallel on the initial sample.

🧮 The 5-Point Hantavirus Clinical Screen

Before specific serological results return, clinicians can use the 5-point hantavirus CBC screen — a rapid clinical decision tool using routine blood work available in any hospital within 1–2 hours.

The 5 findings to look for on a CBC with differential:

1. Thrombocytopenia — platelet count below 150,000/µL (normal: 150,000–400,000). Often dramatically low (50,000–80,000).
2. Hemoconcentration — elevated hematocrit (>50% in males, >45% in females), indicating plasma is leaking out of blood vessels into tissues.
3. Leukocytosis with left shift — elevated white blood cell count with increased band forms (immature neutrophils).
4. Immunoblasts — atypical activated lymphocytes comprising >10% of the lymphocyte differential. This finding is highly characteristic of hantavirus and is rarely prominent in other infections.
5. Normal or mildly abnormal renal function with low platelets — helping distinguish HPS from HFRS and other causes of thrombocytopenia.

Note: These findings are not exclusively diagnostic for hantavirus — similar changes can occur in ehrlichiosis, dengue fever, and other infections. But combined with the clinical picture and rodent exposure history, they powerfully support a presumptive diagnosis within hours of presentation.

📸 Chest Imaging in Hantavirus

Chest X-ray and CT findings in HPS are distinctive and evolve rapidly with the disease:

Chest X-Ray Progression:

• Early: Subtle bilateral interstitial infiltrates — the lungs begin accumulating fluid
• Mid-stage: Bilateral airspace consolidation spreading from the hila outward
• Severe: Complete bilateral "white-out" — both lung fields opacified with fluid, indistinguishable from severe ARDS

Chest CT findings:

• Bilateral ground-glass opacities — predominantly basal and peribronchovascular
• Bilateral pleural effusions in 50–80% of cases (a useful distinguishing feature)
• No cavitation, no lung nodules, no mediastinal lymphadenopathy
• Septal thickening ("crazy paving") in some severe cases

Echocardiogram:

Critically important for ECMO candidacy evaluation and for distinguishing HPS-associated cardiogenic shock from pure respiratory failure. HPS typically causes profound reduction in left ventricular ejection fraction during the acute phase (often below 45%). This myocardial depression distinguishes HPS from typical ARDS and identifies patients who need VV vs VA ECMO support.

🔄 Differential Diagnosis

Conditions that can mimic hantavirus and must be excluded:

The combination of rodent exposure + thrombocytopenia + immunoblasts + bilateral pulmonary infiltrates is highly specific for HPS. Clinicians in non-endemic areas may not consider hantavirus without an explicit exposure history — always volunteer this information.